IEA Featured Media Posts

Patients in the UK and across the world will suffer from Labour's plans for a new state-run body to manufacture cheap medicines, says the IEA's Associate Director Kate Andrews. Responding to plans set out in Jeremy Corbyn's speech to Labour Party conference, Kate said "medical patents encourage manufacturers to create new, innovative drugs, which patients ... Continue reading

"Removing all profit motive from healthcare is likely to worsen problems that already exist in the NHS" says Kate Andrews, Associate Director at the Institute of Economic Affairs. Kate was responding to the announcement made in Jeremy Corbyn's speech to Labour Party Conference that the party would set up a new state-run drugs manufacturer to ... Continue reading

The £1.8bn cash injection for the NHS will not deliver much-needed improvements to health outcomes or efficiencies in the system, says Kristian Niemietz, Head of Political Economy at the Institute of Economic Affairs. Writing in the Daily Telegraph, Kristian argues change is impossible while we pretend "that there are only two health systems in the ... Continue reading

Victoria Hewson, the IEA's Head of Regulatory Affairs, busts the no-deal myths around the supply of medicines in a piece for the Telegraph. Victoria notes that while people are rightly concerned about interruptions to medical supplies, concerns about tariffs, regulations, and logistical challenges to supply are overblown. Instead, she argues that the current risks to ... Continue reading

As City A.M. asks "Is Britain overreacting to the idea that the NHS might be 'on the table' in US trade negotiations, Victoria Hewson argues yes. The IEA's Senior Counsel from the International Trade and Competition Unit argues that it shouldn't matter who provides the service, so long as it is good quality and free ... Continue reading

Kate Andrews, Associate-Director of the Institute of Economic Affairs, is quoted in the Daily Mail, responding to President Trump's comments that the NHS should be on the table in future US-UK trade talks. Kate argues that the US is not interested in providing NHS services, rather in "expanding the drugs market" and potentially widening access ... Continue reading

Kate Andrews, IEA Associate Director, writes for The Telegraph, outlining the changes needed if the NHS is to truly deliver world-class outcomes for patients. Far from being the ‘envy of the world’, international comparisons of health system performance almost always rank the NHS the bottom third, on a par with the Czech Republic and Slovenia. The data ... Continue reading